Lake Street Keeps Their Buy Rating on Profound Medical (PRN)

Lake Street analyst Ben Haynor reiterated a Buy rating on Profound Medical today and set a price target of $12.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, Haynor is an analyst with an average return of -13.9% and a 29.02% success rate. Haynor covers the Healthcare sector, focusing on stocks such as Senseonics Holdings, Profound Medical, and Treace Medical Concepts.

In addition to Lake Street, Profound Medical also received a Buy from Stifel Nicolaus’s Rick Wise in a report issued on March 6. However, on March 7, TipRanks – DeepSeek reiterated a Hold rating on Profound Medical (TSX: PRN).

Based on Profound Medical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of C$8.33 million and a GAAP net loss of C$11.4 million. In comparison, last year the company earned a revenue of C$3.71 million and had a GAAP net loss of C$5.33 million

Based on the recent corporate insider activity of 31 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PRN in relation to earlier this year.